Cary Street Partners Investment Advisory LLC Tilray Brands, Inc. Transaction History

Cary Street Partners Investment Advisory LLC

$2.63 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$2.36 - $3.35 $132 - $187	-56 Reduced 17.55%	263 $0
Q4 2022 Feb 14, 2023	BUY	$2.58 - $4.68 $823 - $1,492	319 New	319 $0
Q4 2020 Feb 12, 2021	SELL	$4.82 - $10.1 $1,928 - $4,040	-400 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$4.7 - $8.7 $1,880 - $3,479	400 New	400 $2,000

Others Institutions Holding TLRY

# of Institutions

405

Shares Held

99.8M

Call Options Held

8.6M

Put Options Held

8.9M

Morgan Stanley New York, NY

10M
Shares

$14.9 Million
0.0% of portfolio
Toroso Investments, LLC Massapequa, NY

9.71M
Shares

$14.4 Million
0.2% of portfolio
Susquehanna International Group, LLP Bala Cynwyd, PA

7.65M
Shares

$11.3 Million
0.0% of portfolio
ETF Managers Group, LLC Summit, NJ

7.6M
Shares

$11.2 Million
0.69% of portfolio
Highbridge Capital Management LLC New York, NY

5.19M
Shares

$7.68 Million
2.73% of portfolio

View Full List

About Tilray Brands, Inc.

Ticker TLRY
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 611,401,984
Market Cap $905M
Description
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Welln...

More about TLRY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cary Street Partners Investment Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cary Street Partners Investment Advisory LLC with notifications on news.

Account